miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
about
MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivityAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27amiR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.Role of non-coding RNAs in maintaining primary airway smooth muscle cellsColorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancerNovel classes of non-coding RNAs and cancerEwing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer.Regulation of multidrug resistance by microRNAs in anti-cancer therapyMicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.MicroRNAs in colorectal cancer as markers and targets: Recent advances.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyMicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage.MicroRNAs are important regulators of drug resistance in colorectal cancer.Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells.Genome-wide miRNA response to anacardic acid in breast cancer cells.Epigenetic impacts of ascorbate on human metastatic melanoma cells.Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulationZNF139 increases multidrug resistance in gastric cancer cells by inhibitingmiRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
P2860
Q26799044-945A2AF8-6053-4B1C-AF7C-448B1662A056Q27024427-BCE9F7E3-BC6E-47BE-9C0A-C20CCC146A5EQ28547382-A21CFA36-FC35-4D76-B719-F2B56D88A687Q33591648-B6E188FB-1E3E-4328-8E23-0D1E09C8AE34Q33690703-B5F858CC-3DF1-496E-AC9D-33138FC4316AQ33720978-86397DBF-7EB8-4D92-8D22-0F043B422BA7Q34432845-8171FFDD-61BE-4D42-B5DD-C32A51DDEF53Q34487177-E0D102B8-F956-4406-AA3C-EE745459DDA7Q34626744-4FDC99CB-2B51-4E39-9442-88B7C2915440Q35672735-6073C1F9-C52E-467A-97A6-A19A8F54A255Q35955331-52E83809-008E-4D64-8BF5-A3B50562A7E4Q36140898-3C37E449-348B-4E49-887B-A058B55F9553Q36209417-D181672D-99A7-42A8-B251-53AD0BC0D419Q36939163-0F74124B-F0BC-4B01-B038-40D8E3E47C85Q37277833-2EC4526F-63CF-475C-9D53-345735755D1FQ37587311-6A5BD79E-0215-4166-A286-95CB74026A3DQ37700939-4530DAD5-A488-4154-A72C-14D38FC556DCQ37708024-8109B64E-4135-40F9-9569-FE12ABD5F26BQ38172970-4C9B8304-EF4B-47A6-8725-0ED0FAC7944BQ38202662-28E91265-F094-4087-B747-E8B54AF94327Q38814178-799B003E-7EFA-4C7C-96E9-4077DAB244C9Q38826542-1749D49D-D9C3-4E28-956A-8B5BBCD04A62Q38939457-A805EA0E-D63A-4783-B5E1-E741E19288F7Q38953085-46472887-7553-4F82-B1AC-0DD38EB8667AQ38996596-99272759-0AD8-46F5-B028-60C98108EC55Q39016759-07C19328-4168-455D-AD28-D9B7D2A81EB7Q39070721-CBA1D714-8016-4414-8F6A-C54C8CA209DAQ39112720-28DC4256-26E2-434D-8754-76FC9AA79D8DQ39134104-FAFEC158-2D39-4100-AAFD-527DCB353A79Q39438832-515466FD-DF1F-434B-8D14-815B984AFAC8Q39985681-9F9C261A-37DA-449E-A1BD-2545A094A59CQ41491494-83EDD926-921E-4C07-98A0-DEC10DBA4B16Q42002131-D9902BE6-A578-42DA-97A7-0CB3DA582440Q47110047-8727C701-8CAA-4F31-928F-53AE30216556Q49569092-6512700B-A187-49E2-A008-A96FF6609C5DQ50880824-3FEBBD8E-87B5-4C92-95EB-D8F3DFA2FB70Q55403266-33BE402C-ED60-4FBB-881A-87D33C1EFE97Q58706780-4F238310-471F-449D-9B75-A753C0F55B90Q58763916-E4950141-8B0C-4C16-BB04-2F66EE048FAAQ58799032-32CFD1D1-115A-468C-9DBD-4B35870B4F47
P2860
miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@en
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@nl
type
label
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@en
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@nl
prefLabel
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@en
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@nl
P2093
P2860
P356
P1476
miR-1915 inhibits Bcl-2 to mod ...... an colorectal carcinoma cells.
@en
P2093
P2860
P356
10.1002/MC.21832
P577
2011-11-28T00:00:00Z